The Sterile-20 (Ste20) family of the protein kinome includes both the p21-activated kinase (PAK) and germinal center kinase III (GCKIII) families. These proteins are critical for a variety o cellular functions including cell polarization and migration, cell cycle, apoptosis and axon outgrowth and regeneration. Dysregulation of Ste20 kinases is frequently observed in cancer and may be an important causative factor in cerebral cavernous malformations. Consequently, understanding the molecular basis for regulation of the Ste20 kinases is biologically and clinically important. In this proposal we will investigate the structural basis for normal and alteed regulation of two important sub-families of the Ste20 kinases, the type II PAKs and the GCKIII kinases, and will investigate the molecular level determinants of differences in specificity between the two sub-families.
In Aim 1 we will investigate the regulation of type II PAKs. Type II PAKs encompass the proteins PAK4, PAK5 and PAK6. Whereas the molecular basis for how type I PAKs (PAK1, PAK2 and PAK3) are regulated by inter- molecular autoinhibition is well established, the type II PAKs are not regulated by the same mechanism. Type II PAKs do not include a conserved AID (autoinhibitory domain), and although some studies suggest that interaction of type II PAKs with GTPases is important for localization but not kinase activity, there is also intriguing data suggesting that the N-terminal region of the type II PAKs can play a role in autoregulation. Therefore, in Aim 1 we will investigate the molecular basis for type II PAK regulation.
In Aim 2 we investigate the regulation of the GCKIII class of protein kinases: MST4, STK24 and STK25. The regulation of this family of protein kinases is not understood at the molecular level. However, each of these proteins uses a C-terminal region to directly interact with the cerebral cavernous malformation-associated protein CCM3 which may be a regulatory interaction. Therefore in Aim 2 we will determine the structural basis for GCKI association with CCM3, and CCM3-mediated modulation of GCKIII kinase activity.
In Aim 3, we propose to probe the structural determinants of substrate selectivity by Ste20 kinases through a combination of X-ray crystallography and structure-guided mutagenesis. The Ste20 family includes closely related kinases having drastically different phosphorylation motifs, providing a unique and unprecedented opportunity to probe the structural requirements for substrate recognition through the introduction of exchange mutants. Overall, the studies proposed here will significantly improve our understanding of Ste20 kinase regulation and specificity, and will provide a better understanding of the atomic-level mechanisms that are disrupted in cancer and cerebral cavernous malformations.

Public Health Relevance

The Ste20 kinases are important in multiple forms of cancer and in the common disorder, cerebral cavernous malformation (CCM). The studies proposed provide a comprehensive investigation into the molecular level regulation mechanisms and substrate specificity of two important sub-families of this group of kinases, provide new opportunities to understand the molecular basis of disease and, potentially, facilitate new therapeutic avenues.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM102262-04
Application #
8828240
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Dunsmore, Sarah
Project Start
2012-08-01
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
4
Fiscal Year
2015
Total Cost
$316,350
Indirect Cost
$126,350
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06510
Stiegler, Amy L; Boggon, Titus J (2018) The N-Terminal GTPase Domain of p190RhoGAP Proteins Is a PseudoGTPase. Structure 26:1451-1461.e4
Miller, Chad J; Turk, Benjamin E (2018) Homing in: Mechanisms of Substrate Targeting by Protein Kinases. Trends Biochem Sci 43:380-394
Ha, Byung Hak; Boggon, Titus J (2018) CDC42 binds PAK4 via an extended GTPase-effector interface. Proc Natl Acad Sci U S A 115:531-536
Zhang, Eric Y; Ha, Byung Hak; Boggon, Titus J (2018) PAK4 crystal structures suggest unusual kinase conformational movements. Biochim Biophys Acta Proteins Proteom 1866:356-365
Ha, Byung Hak; Boggon, Titus J (2018) The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization. J Biol Chem 293:1642-1650
Li, Xiaofeng; Tao, Yeqing; Murphy, James W et al. (2017) The repeat region of cortactin is intrinsically disordered in solution. Sci Rep 7:16696
Chen, Catherine; Nimlamool, Wutigri; Miller, Chad J et al. (2017) Rational Redesign of a Functional Protein Kinase-Substrate Interaction. ACS Chem Biol 12:1194-1198
Stiegler, Amy L; Boggon, Titus J (2017) p190RhoGAP proteins contain pseudoGTPase domains. Nat Commun 8:506
Morse, Elizabeth M; Sun, Xiaowen; Olberding, Jordan R et al. (2016) PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape. J Cell Sci 129:380-93
Miller, Chad J; Turk, Benjamin E (2016) Rapid Identification of Protein Kinase Phosphorylation Site Motifs Using Combinatorial Peptide Libraries. Methods Mol Biol 1360:203-16

Showing the most recent 10 out of 22 publications